Drug Farm today announced that preliminary immunologic and clinical results from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented in a podium session at ...

Drug Farm today announced that preliminary immunologic and clinical results from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented in a podium session at ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, today announced that the Mount Sinai Health ...

American Society of Gene and Cell Therapy 29th Annual Meeting (ASGCT) TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference 3rd ...

This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...

Orvida Pharma (formerly Kamari Pharma), a privately held clinical-stage biotechnology company developing first and best-in-class treatments for rare and severe genetic skin diseases, today announced ...

GeneCentric, a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for ...

The peripheral nervous system begins to take shape long before birth. This crucial stage of human development can’t be ...

More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not ...

Tissue Cryopreservation Preserves More Future Options The way a patient's tumor tissue is preserved after surgery is ...

Neurocrine Biosciences is in advanced talks to acquire Soleno Therapeutics for just over $2.5 billion, or low-to-mid $50s per share. Read the full analysis now.

a) CBSE Board 10th Result 2026 of candidates who appeared in all examinations will be declared based on their performance. b) If a student could only attempt four examinations before the remaining ...